Xopenex Hfa Aerosol, Metered
Product Images NDC 27437-056

19 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Xopenex Hfa (NDC 27437-056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (905559df C984 469d B6b1 A38fdc320471 01)

Chemical Structure (905559df C984 469d B6b1 A38fdc320471 01)
Chemical structure diagram showing the molecular structures of levalbuterol and tartrate, the active ingredients of XOPENEX HFA (levalbuterol tartrate).*
FDA Label Image

Figure 1 (905559df C984 469d B6b1 A38fdc320471 02)

Figure 1 (905559df C984 469d B6b1 A38fdc320471 02)
Line chart showing the mean percentage change in FEV1 over 6 hours on Day 1 for three groups: XOPENEX HFA inhalation aerosol, Racemic Albuterol HFA 180 mcg, and placebo. The XOPENEX HFA and Racemic Albuterol groups show a rapid increase followed by a gradual decline, while the placebo group remains consistently lower throughout the time course.*
FDA Label Image

Figure 1 (905559df C984 469d B6b1 A38fdc320471 03)

Figure 1 (905559df C984 469d B6b1 A38fdc320471 03)
A line chart depicting mean percent change in FEV1 over 6 hours on Day 56 for three groups: Xopenex HFA Inhalation Aerosol (n=187), Albuterol HFA 180 mcg (n=105), and placebo (n=95). The chart shows % change on the vertical axis and time in hours on the horizontal axis, comparing the pulmonary function response of each treatment over time.*
FDA Label Image

Figure 1 (905559df C984 469d B6b1 A38fdc320471 04)

Figure 1 (905559df C984 469d B6b1 A38fdc320471 04)
An instructional diagram showing a side view and top view of the XOPENEX HFA inhaler. The side view labels the canister, actuator, mouthpiece, cap, and dose indicator. The top view highlights the dose indicator display window, pointer, press here area, and targeting rings to guide proper use.*
FDA Label Image

Figure 2d (905559df C984 469d B6b1 A38fdc320471 05)

Figure 2d (905559df C984 469d B6b1 A38fdc320471 05)
Illustration of a circular dose counter dial displaying numbers 0, 20, and 40 with an arrow pointer, likely indicating remaining doses for a metered-dose inhaler of XOPENEX HFA (levalbuterol tartrate) aerosol.*
FDA Label Image

Figure 3 (905559df C984 469d B6b1 A38fdc320471 06)

Figure 3 (905559df C984 469d B6b1 A38fdc320471 06)
An instructional illustration showing a hand holding an inhaler (aerosol, metered dose) with the other hand removing the protective cap from the mouthpiece. The image demonstrates proper handling of the device before use.*
FDA Label Image

Figure 4 (905559df C984 469d B6b1 A38fdc320471 07)

Figure 4 (905559df C984 469d B6b1 A38fdc320471 07)
An instructional diagram showing a person holding an inhaler device near their mouth, demonstrating the proper technique to use the inhaler by pressing down on the canister while inhaling.*
FDA Label Image

Figure 5 (905559df C984 469d B6b1 A38fdc320471 08)

Figure 5 (905559df C984 469d B6b1 A38fdc320471 08)
An instructional line drawing showing a person holding a metered-dose inhaler with the canister oriented downward. An arrow points downward on the canister, indicating a pressing action to release the aerosol medication. The person is positioned as if about to inhale the medication orally.*
FDA Label Image

Figure 6 (905559df C984 469d B6b1 A38fdc320471 09)

Figure 6 (905559df C984 469d B6b1 A38fdc320471 09)
An instructional illustration showing a person holding an aerosol metered-dose inhaler near their mouth with arrows indicating the inhalation process. The image demonstrates the correct positioning and use of the inhaler for oral administration.*
FDA Label Image

Figure 7 (905559df C984 469d B6b1 A38fdc320471 10)

Figure 7 (905559df C984 469d B6b1 A38fdc320471 10)
An instructional line drawing showing a person holding an oral metered-dose inhaler near their mouth. The person is positioning their finger on the center of the targeting rings of the inhaler, demonstrating correct use for inhalation.*
FDA Label Image

Figure 8 (905559df C984 469d B6b1 A38fdc320471 11)

Figure 8 (905559df C984 469d B6b1 A38fdc320471 11)
Black and white line drawing showing a hand holding an aerosol inhaler device. The inhaler has a mouthpiece and a canister inserted into it. In the background, there is a sink with a faucet and a small container with a lid nearby. The image likely illustrates preparation or use of an inhaler device.*
FDA Label Image

Figure 9 (905559df C984 469d B6b1 A38fdc320471 12)

Figure 9 (905559df C984 469d B6b1 A38fdc320471 12)
An instructional line drawing showing how to insert a metered dose inhaler canister into its actuator. The image features two hands, one holding the bottom part of the inhaler and the other about to place the canister inside, indicated by an upward-pointing arrow.*
FDA Label Image

Figure 10 (905559df C984 469d B6b1 A38fdc320471 13)

Figure 10 (905559df C984 469d B6b1 A38fdc320471 13)
An instructional illustration showing a hand using an inhaler with a mouthpiece spacer device. The sequence appears to demonstrate priming or cleaning steps involving water, with a sink faucet, a container with lid, and water splashing out from the spacer.*
FDA Label Image

Figure 11 (905559df C984 469d B6b1 A38fdc320471 14)

Figure 11 (905559df C984 469d B6b1 A38fdc320471 14)
An instructional illustration showing two hand positions using an oral aerosol inhaler. The first image demonstrates correct finger placement on the center of targeting rings with the inhaler spray depicted as 'NOT CLOGGED.' The second image shows similar finger placement but indicates the spray is 'CLOGGED,' illustrating the difference in spray function.*
FDA Label Image

Figure 2a (76121625 67a5 4464 8f35 4740e9c71196 122 2)

Figure 2a (76121625 67a5 4464 8f35 4740e9c71196 122 2)
An illustration showing a circular dial or gauge with markings at 80 and 200, likely representing dose count or usage measurement. The center features a pointer indicating a value between the markings.*
FDA Label Image

Figure 2b (76121625 67a5 4464 8f35 4740e9c71196 122 3)

Figure 2b (76121625 67a5 4464 8f35 4740e9c71196 122 3)
Illustration showing the dosage counter dial of XOPENEX HFA aerosol inhaler, indicating doses remaining between 180 and 200. The dial has concentric circular markers and a pointer highlighting the current dose range.*
FDA Label Image

Figure 2c (76121625 67a5 4464 8f35 4740e9c71196 122 4)

Figure 2c (76121625 67a5 4464 8f35 4740e9c71196 122 4)
Illustration showing a circular dose counter dial with numbers 20, 50, and 180 marked around the edge, indicating remaining doses in a metered aerosol inhaler, likely associated with XOPENEX HFA (levalbuterol tartrate) inhaler usage instructions or labeling.*
FDA Label Image

Principal Display Panel Trade Canister Label 45 Mcg 200 Actuations (905559df C984 469d B6b1 A38fdc320471 15)

Principal Display Panel Trade Canister Label 45 Mcg 200 Actuations (905559df C984 469d B6b1 A38fdc320471 15)
XOPENEX HFA 45 mcg/actuation inhalation aerosol label shows this Lupin Pharmaceuticals, Inc. product containing 200 metered inhalations for oral inhalation use. The label states the active ingredient as levalbuterol tartrate and includes storage instructions, warnings, and manufacturer details. The net content is 15 g.*
FDA Label Image

Principal Display Panel Trade Carton 45 Mcg 200 Actuations (905559df C984 469d B6b1 A38fdc320471 16)

Principal Display Panel  Trade Carton  45 Mcg 200 Actuations (905559df C984 469d B6b1 A38fdc320471 16)
XOPENEX HFA (levalbuterol tartrate) Inhalation Aerosol 45 mcg/actuation metered aerosol for oral inhalation. The label shows a 200 metered inhalations package by Lupin Pharmaceuticals, Inc. The carton includes warnings, pharmacist instructions, storage conditions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.